tPA in the injured central nervous system: different scenarios starring the same actor?
about
Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsNonsurgical therapy for hydrocephalus: a comprehensive and critical reviewPharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disordersThe tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humansThe role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantation.Relevance of Post-Stroke Circulating BDNF Levels as a Prognostic Biomarker of Stroke Outcome. Impact of rt-PA Treatment.Identification of a neurovascular signaling pathway regulating seizures in miceEffect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression.Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery.tPA Deficiency in Mice Leads to Rearrangement in the Cerebrovascular Tree and Cerebroventricular Malformations.Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression.Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.ADAMTS-4 in central nervous system pathologies.Endovascular Interventions in Acute Ischemic Stroke: Recent Evidence, Current Challenges, and Future Prospects.tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.Does treatment with t-PA increase the risk of developing epilepsy after stroke?Disseminated intravascular coagulation with increased fibrinolysis during the early phase of isolated traumatic brain injury.Effects of Korean Red Ginseng extract on tissue plasminogen activator and plasminogen activator inhibitor-1 expression in cultured rat primary astrocytes.Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons.Comparative effects of pulsatile and nonpulsatile flow on plasma fibrinolytic balance in pediatric patients undergoing cardiopulmonary bypass.Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.
P2860
Q26765956-0E86A5C4-7DAC-430A-8A4B-75C25D270DF7Q28079392-752D92E7-D05E-418A-8892-6F1CC3EEB87FQ29048615-C5B19322-8170-42F8-B3D0-9772F1966B3AQ30528502-5517A018-EAC5-4C4E-9411-D21BCA21D46FQ33562755-68561A29-A084-40BA-9409-5161B4E33F72Q35582569-9084E920-4143-47E0-BECD-84E0C17C3444Q35808437-3F557959-7411-4D6A-8CEC-8A1F57C534A9Q35935089-793D2762-BBAB-4885-B3C1-8C2ACA6D6CA8Q36223606-FA6FC0C3-854F-4E88-B257-2D7EB3C0C4CFQ36307057-63E7E0D0-50BD-4714-800A-7B56396F4F07Q36328770-99013205-A089-40F2-9CC6-4B10BA5B07DFQ36605041-CA05FA72-9FEE-494A-BBC5-C7EE1CFA0F24Q37523317-6F39D782-8EE8-4435-ADD4-1461E41CF219Q38770884-890E94D8-A505-4DBC-8AB2-D99064DA8A74Q38843481-C10914C5-658A-4289-AB99-968F627DF2ABQ38965982-1E5B1D29-D76B-4AE0-8193-5A3675F640B9Q40702493-63C4C777-03F1-453B-9FC7-6516BD893D3FQ41502658-D20A4061-E6BC-4EF4-A67B-8F376084198EQ42088308-69C3B87B-975E-465B-B1E1-4C7C86638F2CQ42455239-6FD00F0F-9486-4A98-8E06-B6B1441A39C9Q45266950-DFF9231A-A4B3-4383-A940-A7B1321BEB2BQ47931181-DEAA522A-935C-476D-BB08-6A769E327F40Q52665673-5B403913-47CB-4F6E-9836-E7C79B9F5FB7
P2860
tPA in the injured central nervous system: different scenarios starring the same actor?
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
tPA in the injured central nervous system: different scenarios starring the same actor?
@en
tPA in the injured central nervous system: different scenarios starring the same actor?
@nl
type
label
tPA in the injured central nervous system: different scenarios starring the same actor?
@en
tPA in the injured central nervous system: different scenarios starring the same actor?
@nl
prefLabel
tPA in the injured central nervous system: different scenarios starring the same actor?
@en
tPA in the injured central nervous system: different scenarios starring the same actor?
@nl
P2093
P50
P1433
P1476
tPA in the injured central nervous system: different scenarios starring the same actor?
@en
P2093
Evelyne Emery
Marina Rubio
Sighild Lemarchant
P304
P356
10.1016/J.NEUROPHARM.2011.10.020
P577
2011-11-07T00:00:00Z